Phase 3 study expected to enroll 6,000 participants starting in the Northern Hemisphere - Participants will include adults ...

"MediciNova concludes subject enrolment in trial of MN-166" was originally created and published by Clinical Trials Arena, a ...

The poster, titled "Study Design of a Phase 2a Double-Blind Placebo-Controlled Trial of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis," will outline the clinical trial design ...

Actio Biosciences has administered the initial dose to a subject in the Phase Ia clinical trial of ABS-1230, a potassium ...

Based on the results from this trial, ACI-35.030 was selected for further clinical testing and is now being investigated in the ongoing Phase 2b ReTain trial ( NCT06544616 ). It is the first active ...

Tiziana Life Sciences (TLSA) announced that it will present a scientific poster at the 41st Congress of the European Committee for Treatment and ...

Annual Meeting 2025, findings were shown from the Phase IIIa REDEFINE 2 trial, assessing Novo Nordisk’s fixed-dose ...

This phase II/III double-blind study assessed efficacy and safety of cediranib with standard chemotherapy as initial therapy for advanced non–small-cell lung cancer (NSCLC). Although all authors ...

The COMPASS PWS was a 12-week, double-blind, randomized, placebo-controlled global Phase 3 trial that evaluated intranasal carbetocin 3.2 mg three times daily in 175 enrolled children and adults aged ...

Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer One hundred sixty-two patients ...